Lung cancer is the leading cause of cancer-related death in the united States. One major impediment to effective therapy is our inadequate understanding of how lung caner escapes immune surveillance and inhibits antitumor immunity. Interleukin 10 (IL- 10) is a potent immunosuppressive cytokine present in the local tumor environment in non--small cell lung cancer (NSCLC). In this proposal we evaluate the function and regulation of IL-10 in NSCLC in both a murine model in vivo and in human cells in vitro. In vitro, IL-10, murine lung tumors grow more rapidly and lead to decreased survival compared to controls. We hypothesize that IL- 10 inhibits specific tumor antigen-presentation and /or recognition in vivo. To test this hypothesis we will evaluate the capacity of IL- 10 transgenic mice to present specific tumor antigen and for IL-10 to inhibit the activation and function of human antigen-presenting cells in vitro. In addition to tumor cells, other cellular components of the tumor microenvironment may contribute to tumor-associated immunosuppression. NSCLC-derived prostaglandin E@ (PGE2) potently induces lymphocyte and macrophage IL-10 production. While the interaction between lung tumor cells and mononuclear leukocytes is complex, one focus of our in vitro studies will be to identify the mechanism(s) by which human NSCLC produce PGE2 and up-regulate leukocyte-derived IL-10. We hypothesize that activation of cyclooxygenase-2 (COX-2), the cytokine-inducible isoform of cyclooxygenase, is primarily responsible for high level PGE2 production by lung tumor cells.
The specific aims of this research are: 1) To determine the in vivo immunoregulatory role of IL-10 in a murine model of NSCLC, 2) To evaluate the relationship between COX-2 expression, IL-10 induction and antitumor responses in vivo, 3) To define the COX-2-dependent pathway regulating human NSCLC-derived PGE2 formation and 4) To evaluate the biologic consequences of IL-10 on the generation of specific anti-tumor immunity by human antigen-presenting cells. Tumor-derived prostaglandins may play an important role in augmenting lymphocyte production of inhibitory cytokines such as IL-10 that interfere with effective host cell-mediated anti-tumor immune responses. We anticipate that this study will add to our understanding of the complex interaction between pulmonary tumor- derived PGE2 and the cytokine network at the tumor site.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA071818-01A1
Application #
2010187
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1997-04-04
Project End
2000-03-31
Budget Start
1997-04-04
Budget End
1998-03-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Pold, Mehis; Zhu, Li X; Sharma, Sherven et al. (2004) Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer. Cancer Res 64:1853-60
Gardner, Brian; Zhu, Li X; Roth, Michael D et al. (2004) Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol 147:95-8
Yang, Seok-Chul; Hillinger, Sven; Riedl, Karen et al. (2004) Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clin Cancer Res 10:2891-901
Zhu, Li X; Sharma, Sherven; Gardner, Brian et al. (2003) IL-10 mediates sigma 1 receptor-dependent suppression of antitumor immunity. J Immunol 170:3585-91
Hillinger, Sven; Yang, Seok-Chul; Zhu, Li et al. (2003) EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model. J Immunol 171:6457-65
Heuze-Vourc'h, Nathalie; Zhu, Li; Krysan, Kostyantyn et al. (2003) Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells. Cancer Res 63:766-70
Sharma, Sherven; Stolina, Marina; Yang, Seok-Chul et al. (2003) Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin Cancer Res 9:961-8
Batra, Raj K; Lin, Ying; Sharma, Sherven et al. (2003) Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism. Cancer Res 63:642-6
Gardner, Brian; Zu, Li X; Sharma, Sherven et al. (2002) Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta. Biochem Biophys Res Commun 290:91-6
Huang, M; Batra, R K; Kogai, T et al. (2001) Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther 8:612-8

Showing the most recent 10 out of 20 publications